FREDUN PHARMACEUTICALS LIMITED Fredun Pharmaceuticals Limited reported earnings results for the fourth quarter ended March 31, 2024. For the fourth quarter, the company reported sales was INR 1,172.14 million compared to INR 797.27 million a year ago. Revenue was INR 1,180.33 million compared to INR 798.04 million a year ago.
Net income was INR 50.62 million compared to INR 38.92 million a year ago. Basic earnings per share from continuing operations was INR 10.77 compared to INR 8.59 a year ago. Diluted earnings per share from continuing operations was INR 10.77 compared to INR 8.59 a year ago.
